- Home
- ADUS vs SLNO Comparison
ADUS vs SLNO Comparison
Compare ADUS & SLNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ADUS | SLNO |
|---|---|---|
| Founded | 1979 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Nursing Services | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 2.3B |
| IPO Year | 2009 | 2014 |
Fundamental Metrics
Financial Performance| Metric | ADUS | SLNO |
|---|---|---|
| Price | $94.36 | $30.47 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 10 | 11 |
| Target Price | ★ $135.40 | $105.27 |
| AVG Volume (30 Days) | 170.1K | ★ 1.5M |
| Earning Date | 05-04-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 23.40 | ★ 108.90 |
| EPS | ★ 5.22 | 0.39 |
| Revenue | N/A | ★ $1,450,788.00 |
| Revenue This Year | $9.17 | $150.65 |
| Revenue Next Year | $4.64 | $56.10 |
| P/E Ratio | ★ $18.23 | $76.97 |
| Revenue Growth | N/A | ★ 138.82 |
| 52 Week Low | $94.40 | $29.43 |
| 52 Week High | $124.44 | $89.12 |
Technical Indicators
Market Signals| Indicator | ADUS | SLNO |
|---|---|---|
| Relative Strength Index (RSI) | 28.87 | 30.88 |
| Support Level | N/A | N/A |
| Resistance Level | $118.51 | $41.48 |
| Average True Range (ATR) | 2.90 | 1.83 |
| MACD | -0.43 | -0.30 |
| Stochastic Oscillator | 8.85 | 10.74 |
Price Performance
Historical ComparisonAbout ADUS Addus HomeCare Corporation
Addus HomeCare Corp is engaged in the provision of in-home care services. The Company has three reportable segments: Personal Care, Hospice, and Home Health. The Personal Care segment provides non-medical assistance with activities of daily living, mainly to the elderly, chronically ill, and disabled individuals. The Hospice segment provides physical, emotional, and spiritual care for terminally ill patients and their families. The Home Health segment provides medical services to individuals requiring care during illness or recovery. It generates the majority of its revenue from the Personal Care segment.
About SLNO Soleno Therapeutics Inc.
Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.